A surrogate-based approach for post-genomic partner identification

BMC Biotechnology

Volumn 1, Issue , 2001, Pages

  Pillutla, Renuka C ^a   Hsiao, Ku Chuan ^a   Brissette, Renee ^a   Eder, Paul S ^b   Giordano, Tony ^b   Fletcher, Paul W ^a   Lennick, Michael ^a   Blume, Arthur J ^a   Goldstein, Neil I ^a  

^a DGI BioTechnologies   (United States)

^b Message Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LYMPHOTOXIN; MESSENGER RNA; PEPTIDE; PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER SYSTEM; GENOME ANALYSIS; HUMAN GENOME; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; PROTEIN TARGETING;

EID: 3042520599     PISSN: 14726750     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6750-1-6     Document Type: Article

References (26)

1. Drews J: A historical perspective. Science 2000, 297:1960-1967
2. Scott JK, Smith G: Searching for peptide ligands with an epitope library. Science 1990, 249:386-390
3. Gallop MP, Barrett RW, Dower WJ, Fodor SP, Gordon EM: Applications of combinatorial technologies to drug discovery. I. Background and peptide combinatorial libraries. J Med Chem 1994, 37:1233-1251
4. Yanofsky SD, Baldwin DN, Butler JH, Holden FR, Jacobs JW, Balasubramanian P, Chinn JP, Cwirla SE, Peters-Bhatt E, Whitehorn EA, Tate EH, Akeson A, Bowlin TL, Dower WJ, Barrett RW: High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci USA 1996, 93:7381-73
5. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ: Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996, 273:458-463
6. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Matteakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ: Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997, 276:1696-1699
7. Blume AJ, Beasley J, Goldstein NI: The use of peptides in Diogenesis: A novel approach to drug discovery and phenomics. Biopolymers 2000, 55:347-356
8. Burd CG, Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 1994, 265:615-621
9. Siomi H, Dreyfuss G: RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 1997, 7:345-353
10. Zemmel RW, Kelley AC, Karn J, Butler PJG: Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element. J Mol Biol 1996, 258:763-777
11. Buratti E, Tisminetzky S, Zotti M, Baralle FE: Functional analysis of the interactions between HCV 5′ UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nuc Acid Res 1998, 26:3179-3187
12. Odreman-Macchioli FE, Tisiminetzky SG, Zotti M, Baralle FE, Buratti E: Influence of correct secondary and tertiary RNA folding on the binding of cellular factors to the HCV IRES. Nuc Acids Res 2000, 28:875-885
13. Kruger M, Berger C, Li QX, Welch PJ, Trinz R, Leavitt M, Barber JR, Wong-Staal F: Identification of eIF2Bγ and eIF2γ as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach. Proc Natl Acad Sci USA 2000, 97:8566-8571
14. Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CUT: Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol 1998, 72:4775-4782
15. Bazzoni F, Beutler B: How do tumor necrosis factor receptors work? J Inflamm 1995, 45:221-238
16. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 1992, 13:151-153
17. Heller RA, Kronke M: Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994, 126:5-9
18. Banner D, D'Arcy A, Janes W, Gentz R, Schoenfeld H-J, Broger C, Loetscher H, Lesslauer W: Crystal structure of the soluble human 55kd TNF receptor-human TNF-β complex: Implications for TNF receptor activation. Cell 1993, 73:431-445
19. Hexham MJ, White KD, Carayannopoulos LN, Mandecki W, Brissette R, Yang YS, Capra J: A human immunoglobulin (Ig) alpha3 domain motif directs polymeric Ig receptor-mediated secretion. J Exp Med 1999, 189:747-752
20. Ravera MW, Carcamo J, Brissette R, Alam-Moghe A, Dedova O, Cheng W, Hsiao KC, Shen KI, Tang P, Blume A, Mandecki W: Identification of an allosteric binding site on the transcription factor p53 using a phage-displayed peptide library. Oncogene 1998, 16:1993-1999
21. Tonegawa S: Somatic generation of antibody diversity. Nature 1983, 302:575-581
22. Kocks C, Rajewsky K: Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc Natl Acad Sci USA 1988, 85:8206-8210
23. Wagner SD, Neuberger MS: Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996, 14:441-457
24. Weiss U, Rajewsky K: The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response. J Exp Med 1990, 172:1681-1689
25. Cagney G, Uetz P, Fields S: High-throughput screening for protein-protein interactions using two-hybrid assay. Methods Enzymol 2000, 328:3-14
26. Carcamo J, Ravera MW, Brissette R, Dedova O, Beasley JR, Alam-Moghe A, Wan C, Blume A, Mandecki W: Unexpected frameshifts from gene to expressed protein in a phage-displayed peptide library. Proc Natl Acad Sci USA 1998, 95:11146-11151